INTRODUCTION
The incidence of colorectal cancer in Singapore has been increasing over the last ten years. It is the most common cancer in Singapore when the combined incidences for both genders are taken into account.
(1) Population-based randomised trials have
shown that the use of faecal occult blood test (FOBT) reduces mortality from colorectal cancer, (2) (3) (4) (5) (6) with a possible reduction in cancer incidence being effected through the early detection and removal of colorectal adenomas. 
METHODS
FIT kits were distributed free of charge at the SCS office and through participating stores such as the Guardian pharmacy outlets. The assay of the FIT kit is based on latex particle-linked antigenantibody reaction, which uses murine antibodies to specifically detect human haemoglobin (Hb) in stool. Two kits were given free to each individual. Although individuals with a family history of colorectal cancer were discouraged from participating in the programme, several people managed to obtain the kits.
Each participant was taught how to collect the stool samples in the correct manner and to return the kits within a time frame of up to a week -through designated drop boxes at certain locations in Singapore, by post to the SCS office in sealed waterproof envelopes or returned directly to the society's office premises.
The samples were processed in certified pathology laboratories in Singapore. Test results were available 4-6 weeks after the return of kits. The level of occult blood for a positive test was assigned as 100 ng Hb/mL.
In the event of a negative result, participants were notified The details of surgeries performed and the patients' disease stage are summarised in Table II . One or more polyps were found on colonoscopy in 135 (27.3%) participants. Nearly 85% of these polyps were adenomatous, and nearly 86% of the 135 participants had 1-2 polyps synchronously (Table III) .
Among the remaining 326 participants, 221 (44.7%) had no pathology found on evaluation, 30 (6.1%) had diverticular disease, 67 (13.6%) had haemorrhoids and 8 (1.6%) had inflammatory/infective colitis. Fig. 1 illustrates the sequence of screening adopted in this study. Overall, the PPV of FIT for colorectal neoplasia in our study was 34%. More than half of the participants who had only one positive test were diagnosed with colorectal neoplasia -55.5% of participants had at least one adenoma, while 1.9%
had colorectal carcinoma (data not shown).
DISCUSSION
Colorectal cancer is the most common cancer in Singapore, but unlike breast or cervical cancer, which has established screening programmes, population screening for colorectal cancer in Singapore only began in July 2011. Multiple large studies performed in other countries have shown that colorectal cancer screening using FOBT decreases colorectal cancer mortality. (2) (3) (4) (5) (6) The reported specificity and sensitivity of FIT for colorectal cancer is 93.4%-96.9% and 61.5%-87.5%, respectively. (9) (10) (11) (12) (13) While two previous studies have also evaluated the use of FOBT in Singapore, their sample sizes were smaller than that in our study. (11, 14) We found the compliance rate to be relatively low in our series. of bowel cancers. (15, 16) This may signal the need for more extensive mass population education programmes aimed at improving compliance among the local population.
According to some studies, the PR and PPV of FOBT for colorectal neoplasia in a screened population ranged from 4.8% to 12.9% and 13.3% to 42.7%, respectively, (11, (17) (18) (19) (20) (21) which correlate well with our findings (PR 8.1%; PPV 34.0%). Importantly, more than half of the participants who had only one positive test in our study were subsequently diagnosed with colorectal neoplasia.
This reinforces the importance of repeated screening with multiple stool samples to minimise the risk of false negative testing with
FOBTs. Hyperplastic polyps were previously considered to be lesions with no malignant potential. However, recent studies suggest that hyperplastic polyps may represent precursor lesions of some sporadic colorectal cancers. (22) Therefore, hyperplastic polyps were also included as colorectal neoplasia, together with adenomas and cancers, in our study. There are several limitations to this study. First, there was no follow-up data available for the participants who tested negative on FIT to ascertain whether these had been false negative results. This is a limitation in many similar studies on population screening programmes. Second, the compliance rate among participants was relatively low and nearly a quarter of all participants who tested positive on FIT refused further investigations. However, the authors contend that individuals who default on treatment are likely to be inherent in any screening programme.
In conclusion, the results of this pilot study hint at the potential obstacles that may surface during the implementation of future population-based screening programmes in Singapore. More extensive population education will be required to improve compliance with screening and tackle inhibitions that may be pervasive among the masses. Efforts may also be warranted to address feasibility concerns such as cost effectiveness.
